Roger Medel M.D., Chief Executive Officer at MEDNAX, INC. (MD), sold 63,440 shares at $62.56 ($4.0M) on 2014-11-13, disclosed to the SEC on 2014-11-13.
Scheduled sale ($4.0M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.54 | 42,012 | $2.6M | 66.2% |
| 2 | $62.56 | 21,428 | $1.3M | 33.8% |
| Total | $62.55 avg | 63,440 | $4.0M | 100% |
| Filing → |
| MD | SELL | 2022-01-04 | $5.1M | — | Filing → |
| MD | SELL | 2021-12-30 | $2.5M | — | Filing → |
| MD | SELL | 2021-12-29 | $6.7M | — | Filing → |